DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay

Information source: Samsung Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Latent Tuberculosis Infection

Intervention: 1-step tuberculin skin test (TST) and blood sampling (Other)

Phase: N/A

Status: Completed

Sponsored by: Samsung Medical Center

Official(s) and/or principal investigator(s):
Won-Jung Koh, M.D., Principal Investigator, Affiliation: Samsung Medical Center

Summary

The present study was to evaluate the usefulness of a whole-blood interferon-r release assays (IGRAs) as diagnostic tool of the latent tuberculosis infection for healthcare workers.

Clinical Details

Official title: Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay

Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Primary outcome: Annual Incidence of Tuberculosis Infection Among Newly Employed Doctors and Nurses in Korea

Secondary outcome: Negative Conversion Rate in Follow-up QuantiFERON-TB Gold In-Tube Test (QFT-IT Test) After Treatment of Latent Tuberculosis Infection (LTBI)

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- doctors and nurses newly hired at Samsung Medical Center between February, 2008 and

November, 2008. Exclusion Criteria:

- Non-applicable

Locations and Contacts

Samsung Medical Center, Seoul 135-710, Korea, Republic of
Additional Information

Starting date: January 2008
Last updated: December 6, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017